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denervation, n¼10), RD-3d+MI group (RD performed three days before MI, n¼15),
Metoprolol-3d+MI group (Metoprolol treated three days before MI, n¼15), ACEI-
3d+MI group (Perindopril treated three days before MI, n¼15), and ARB-3d+MI
group (Losartan treated three days before MI, n¼15). Cardiac function, auto-
nomic nervous system parameters (HRV), and neuroendocrine activities (plasma
renin, angiotensin II, aldosterone and norepinephrine Levels) were evaluated 8 weeks
post MI.
Results: Ten of 20 animals in the MI group, 5 of 15 in the RD-3d+MI group, 5 of 15
in the metoprolol-3d+MI group, 7 of 15 in the ACEI-3d+MI group and 8 of 15 in the
ARB-3d+MI group died within the eight week period after coronary artery ligation.
The death rates of the RD-3d+MI group and the metoprolol group were the same and
much less than the MI, ACEI, or ARB groups (P<0.05). The death rate did not differ
between the latter three groups. None in the control and RD group died during the
experiment. There were no signiﬁcant differences in body weight or the infarct size
among all experimental groups eight weeks post-MI. The results showed that the
physiologic beneﬁts of RD on improving cardiac remodeling and function, water and
sodium excretion, autonomic modulation and suppression of RAAS activation were
signiﬁcantly better than any of the three drugs alone and had no effect on normal
controls.
Conclusions: In this post-MI HF animal model, surgical RD provides effective
autonomic modulation, inhibition of the RAAS, improved cardiac remodeling, and
preserved renal function, without affecting normal circulation and cardiopulmonary
function in normal rats. Compared to metoprolol, ACEI, and ARB single drug
therapies, RD alone is more efﬁcacious. These results suggest that RD may be an
effective treatment option for HF, especially in patients who have contraindications to
drug therapy.
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Objectives: To isolate rabbit bone marrow-derived mononuclear cell then synchro-
nous culture rabbit endothelial progenitor cells (EPCs) and smooth muscle progenitor
cells (SPCs), study their biological properties and assess the possibility as the seed
cells for tissue-engineered venous valves.
Methods: Density gradient centrifugation was used to obtain bone marrow blood
mononuclear cells, which were separately cultured with EGM-2 complete medium
containing 5% FBS to be induced to EPC and with EBM-2 medium without VEGF
containing 5% FBS, 20ng/ml PDGF-BB for SPC induction.
Results: EPCs were cultured for 10 days and the cells fused as monolayer, showing a
“stepping stone” appearance and expressing VEGFR-2, vWF and weakly expressing
CD133. Under the transmission electron microscope, W-P bodies could be seen within
the EPCs cytoplasm. Biological functions showed visible EPC grew on the matrigel in
a blood wessel -like form. SPCs was cultured for 14 days and showed speciﬁc features
of the vascular smooth muscle growth, namely, “peak-valley” growth way. SPCs
expressed CD34 and SMA without vWF and VEGF-2 expression myoﬁlaments,
paralleled with the longitudinal axis, could be seen under the electron microscope.
SPCs could not form vessel-like structures on the Matrigel.
Conclusions: Mononuclear cells could be obtained through density gradient centri-
fugation of the bone marrow blood, which could be synchronous cultured to EPCs and
SPCs with high purity, provided seed cells for Venous valve tissue engineering
economical and simply.
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Objectives: Loss of endothelial NO production after arterial injury may contribute to
restenosis, characterized by neointima formation and elastic recoil. Previous studies
have established that bone marrow-derived endothelial progenitor cells (EPCs) play an
important role in vascular repair. In this study, we investigated that hypothesis that
overexpression of vasculoprotective gene endothelial nitric oxide synthase (eNOS) in
EPCs may restore NO production and inhibit neointimal hyperplasia.
Methods: EPCs obtained from rat bone marrow were isolated using a Ficoll density
gradient centrifugation, and expanded in endothelial basal medium. The endothelial
characteristics of EPCs were identiﬁed by immunologic cell chemical staining and
ﬂuorescent labeling. EPCs were transduced with pseudotyped retroviral vectors
expressing human eNOS (eNOS-EPCs) or green ﬂuorescent protein (GFP-EPCs).
eNOS or GFP modiﬁed EPCs were injected directly by intravenous tail vein
after arterial injury and again 24 hours later. Two weeks after transplantation,
eNOS proteins in the rat vessels were assayed by western blot. The morphology of
arterial intima and media was studied by optical microscopy and image analysis
system.
Results: The adherent cells were considered EPCs which had spindle shape and form
blood-island-like structures during development. The adherent cells had many endo-
thelial characteristics. Transduction efﬁciency of EPCs ex vivo was above 90%. eNOS
gene transfer augmented EPCs proliferative activity. eNOS proteins were detected in
the rat vessels. Transfused EPCs may home to the injury site and enhancedC82 JACC Vol 64/16/Suppl C j Octobreendothelialization associated with decreased neointima formation. The antipro-
liferative effect of EPCs is further enhanced by overexpression of eNOS. Furthermore,
eNOS overexpressed EPCs could increase signiﬁcantly endothelium- dependent
vasodilation function (EDVR).
Conclusions: In vitro, eNOS gene transfer enhanced EPCs proliferative activity. In
vivo, eNOS overexpressed EPCs could accelerated reendothelialization and inhibit
neointimal hyperplasia. The results show that gene modiﬁed EPCs facilitate the
strategy of cell transplantation for vascular dysfunction and prevention of restenosis
after angioplasty.
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c-Met overexpression promote reendothelialization and inhibit neointimal
formation after balloon injury
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Objectives: to explore the effect of c-met overexpression in EPCs on reendothelial-
ization after balloon injury.
Methods: EPCs derived from mouse bone marrow were isolated and cultured. 3- (4,
5-dimethylthiazol-2-yl) -2, 5-diphenyltetrazolium bromide assays were used to eval-
uate EPC proliferation. Adenoviral vector expressing c-Met was generated using the
AdEasy system. To evaluate the role of HGF/Met in vascular repair in vivo, we used
balloon-injured rat carotid artery model. Evans Blue dye was administered to evaluate
reendothelialization after 10 days injury, and the neointimal formation was assessed at
21 days following vascular injury.
Results: The effect of HGF on EPC proliferation was examined 48 h after exposure to
different quantities of HGF (range 2-20 ng/ml). The proliferation effect was strongly
dose-dependent and signiﬁcantly increased in c-met-EPCs group compared with EPCs
group. After transfusion of c-met-EPCs or EPCs to balloon-injured rat via vessel,
Evans Blue dye was administered to evaluate reendothelialization after balloon injury.
reendothelialized area was signiﬁcantly larger in c-met-EPCs group than in EPCs
group (64.258.90% vs. 43.217.24%, n¼5, P<0.01). A marked decrease in the
neointimal area and I/M ratio was found in c-met–EPCs compared with EPCs group at
day 21 (0.290.06 vs. 0.630.13, n¼5, P<0.01).
Conclusions: c-Met overexpression improve EPCs proliferation, promote reendo-
thelialization and inhibit neointimal formation after balloon injury.
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Objectives: Serum uric acid (SUA) levels have been used to predict cardiovascular
and all-cause mortality event, but the data have yielded conﬂicting results. We
investigated whether SUA was an independent predictor for cardiovascular or all-
cause mortality with prospective studies by meta-analysis. Serum uric acid (SUA)
levels have been used to predict cardiovascular and all-cause mortality event, but the
data have yielded conﬂicting results. We investigated whether SUA was an inde-
pendent predictor for cardiovascular or all-cause mortality with prospective studies by
meta-analysis.
Methods: Pubmed and Embase were searched without language restrictions for
publications available till April 2013. Only prospective studies on cardiovascular or
all-cause mortality related to SUA levels were included. Pooled adjust relative risk
(RR) and corresponding 95% CI were calculated separately for the highest vs. lowest
category or the lowest vs. middle category.
Results: For the highest SUA, eleven studies with 172, 123 participants were iden-
tiﬁed and analyzed. Elevated SUA increased risk of all-cause mortality (RR 1.24; 95%
CI 1.09-1.42) and cardiovascular mortality (RR 1.37; 95% CI 1.19-1.57). Subgroup
analyses showed that elevated SUA signiﬁcantly increase the risk of all-cause mor-
tality among men (RR 1.23; 95% CI 1.08-1.42), but not in women (RR 1.05; 95% CI
0.79-1.39). Risk of cardiovascular mortality appeared to be more pronounced among
women (RR 1.35; 95% CI 1.06-1.72). The association between extremely low SUA
and mortality was reported in three studies; we did not perform a pooled analysis
because of high degree of heterogeneity in these studies.
Conclusions: Baseline SUA level is an independent predictor for future cardiovas-
cular mortality. Elevated SUA appears to signiﬁcantly increase the risk of all-cause
mortality in men, but not in women. Whether low SUA levels are predictors of
mortality is still inconclusive.
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Objectives: High concentrations of glucose induce apoptosis in cardiomyocytes, and
contribute to diabetic cardiomyopathy. Relaxin-2 and relaxin-3 are two members
of the relaxin peptide family that are cardioprotective. In the present study, weer 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
